| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |